Su Ni Selected Research

Mitogen-Activated Protein Kinases

1/2018

Follistatin-like protein 1 induction of matrix metalloproteinase 1, 3 and 13 gene expression in rheumatoid arthritis synoviocytes requires MAPK, JAK/STAT3 and NF-κB pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Su Ni Research Topics

Disease

9	Osteoarthritis 01/2024 - 04/2015
3	Rheumatoid Arthritis 02/2024 - 01/2018
2	Experimental Arthritis 02/2024 - 01/2018
2	Wounds and Injuries (Trauma) 09/2023 - 09/2019
2	Potassium Deficiency 04/2020 - 01/2019
1	Ankylosing Spondylitis 02/2024
1	Osteophyte 11/2023
1	Disease Resistance 01/2022
1	Disease Progression 01/2018
1	Inflammation (Inflammations) 01/2018

Drug/Important Bio-Agent (IBA)

3	Follistatin-Related ProteinsIBA 03/2020 - 04/2015
2	CollagenIBA 02/2024 - 09/2023
2	Polysaccharides (Glycans)IBA 11/2023 - 01/2021
2	CytokinesIBA 01/2021 - 04/2015
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 02/2024
1	Freund's AdjuvantIBA 02/2024
1	Caspase 3 (Caspase-3)IBA 01/2024
1	zingeroneIBA 11/2023
1	Phospholipid Hydroperoxide Glutathione PeroxidaseIBA 11/2023
1	leonurineIBA 09/2023
1	Antimicrobial PeptidesIBA 01/2022
1	TeaIBA 01/2022
1	theaflavin-3,3'-digallateIBA 01/2022
1	PolyphenolsIBA 01/2022
1	erastinIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	Peroxidase (Myeloperoxidase)IBA 04/2020
1	MicroRNAs (MicroRNA)IBA 09/2019
1	Biomarkers (Surrogate Marker)IBA 09/2019
1	ProteomeIBA 01/2019
1	Mitogen-Activated Protein KinasesIBA 01/2018
1	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 01/2018
1	Collagen Type II (Type II Collagen)IBA 06/2016
1	Matrix Metalloproteinases (MMPs)IBA 06/2016
1	Aggrecans (Aggrecan)IBA 06/2016

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2018